Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Galanin negatively modulates opiate withdrawal via galanin receptor 1.

Holmes FE, Armenaki A, Iismaa TP, Einstein EB, Shine J, Picciotto MR, Wynick D, Zachariou V.

Psychopharmacology (Berl). 2012 Apr;220(3):619-25. doi: 10.1007/s00213-011-2515-x. Epub 2011 Oct 4.

2.

Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.

Hawes JJ, Picciotto MR.

J Comp Neurol. 2004 Nov 22;479(4):410-23. Erratum in: J Comp Neurol. 2005 Sep 12;490(1):98-100.

PMID:
15514977
3.
4.

Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Einstein EB, Asaka Y, Yeckel MF, Higley MJ, Picciotto MR.

Eur J Neurosci. 2013 May;37(9):1541-9. doi: 10.1111/ejn.12151. Epub 2013 Feb 7.

5.
6.

Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.

Lu X, Mazarati A, Sanna P, Shinmei S, Bartfai T.

Neuropeptides. 2005 Jun;39(3):147-52. Epub 2005 Jan 26.

PMID:
15944003
7.

Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.

Le Maître E, Barde SS, Palkovits M, Diaz-Heijtz R, Hökfelt TG.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E536-45. doi: 10.1073/pnas.1221378110. Epub 2013 Jan 22.

8.

Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity.

Page AJ, Slattery JA, Brierley SM, Jacoby AS, Blackshaw LA.

J Physiol. 2007 Sep 1;583(Pt 2):675-84. Epub 2007 Jul 12.

9.

Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice.

He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ.

Neuroscience. 2005;133(2):371-80. Erratum in: Neuroscience. 2007 Feb 23;144(4):1544.

PMID:
15885921
10.

The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.

Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9028-33. Epub 2003 Jul 9.

11.

Changes in galanin and GalR1 gene expression in discrete brain regions after transient occlusion of the middle cerebral artery in female rats.

Holm L, Hilke S, Adori C, Theodorsson E, Hökfelt T, Theodorsson A.

Neuropeptides. 2012 Feb;46(1):19-27. doi: 10.1016/j.npep.2011.11.001. Epub 2011 Dec 22.

PMID:
22197078
12.

Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.

Bilbao A, Cippitelli A, Martín AB, Granado N, Ortiz O, Bezard E, Chen JF, Navarro M, Rodríguez de Fonseca F, Moratalla R.

Psychopharmacology (Berl). 2006 Apr;185(2):160-8. Epub 2006 Feb 10.

PMID:
16470403
13.

Galanin can attenuate opiate reinforcement and withdrawal.

Picciotto MR, Hawes JJ, Brunzell DH, Zachariou V.

Neuropeptides. 2005 Jun;39(3):313-5. Epub 2005 Jan 28. Review.

PMID:
15944028
14.

Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.

Borroto-Escuela DO, Narvaez M, Di Palma M, Calvo F, Rodriguez D, Millon C, Carlsson J, Agnati LF, Garriga P, Díaz-Cabiale Z, Fuxe K.

Biochem Biophys Res Commun. 2014 Sep 26;452(3):347-53. doi: 10.1016/j.bbrc.2014.08.061. Epub 2014 Aug 22.

PMID:
25152404
15.

Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III.

Kim DK, Yun S, Son GH, Hwang JI, Park CR, Kim JI, Kim K, Vaudry H, Seong JY.

Endocrinology. 2014 May;155(5):1864-73. doi: 10.1210/en.2013-2106. Epub 2014 Feb 11.

PMID:
24517231
16.

Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.

Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A.

Neuropsychopharmacology. 2008 Nov;33(12):2878-87. doi: 10.1038/npp.2008.8. Epub 2008 Feb 20.

17.

Protracted manifestations of acute dependence after a single morphine exposure.

Rothwell PE, Thomas MJ, Gewirtz JC.

Psychopharmacology (Berl). 2012 Feb;219(4):991-8. doi: 10.1007/s00213-011-2425-y. Epub 2011 Aug 11.

18.

Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.

Shoblock JR, Maidment NT.

Neuroscience. 2007 Nov 9;149(3):642-9. Epub 2007 Oct 1.

PMID:
17905519
19.

Analysis of the contribution of galanin receptors 1 and 2 to the central actions of galanin-like peptide.

Krasnow SM, Hohmann JG, Gragerov A, Clifton DK, Steiner RA.

Neuroendocrinology. 2004;79(5):268-77. Epub 2004 Jul 8.

PMID:
15249737
20.

Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.

Fan LW, Tien LT, Tanaka S, Ma T, Chudapongse N, Sinchaisuk S, Rockhold RW, Ho IK.

Neuroscience. 2003;121(4):1063-74.

PMID:
14580956

Supplemental Content

Support Center